114 related articles for article (PubMed ID: 8877596)
21. Pharmacokinetic-pharmacodynamic modeling between pinacidil or pinacidil-N-oxide plasma levels and systemic and regional hemodynamic effects in healthy volunteers.
Bellissant E; Chau NP; Thuillez C; Giudicelli JF
Fundam Clin Pharmacol; 1994; 8(5):437-45. PubMed ID: 7875638
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the mechanism of beta 2-agonist-induced activation of the renin-angiotensin system.
Millar EA; McInnes GT; Thomson NC
Clin Sci (Lond); 1995 Apr; 88(4):433-7. PubMed ID: 7789045
[TBL] [Abstract][Full Text] [Related]
23. The practical assessment of compliance with ACE-inhibitor therapy--a novel approach.
MacFadyen RJ; Struthers AD
J Cardiovasc Pharmacol; 1997 Jan; 29(1):119-24. PubMed ID: 9007680
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection.
Trachtman H; Frymoyer A; Lewandowski A; Greenbaum LA; Feig DI; Gipson DS; Warady BA; Goebel JW; Schwartz GJ; Lewis K; Anand R; Patel UD;
Clin Pharmacol Ther; 2015 Jul; 98(1):25-33. PubMed ID: 25807932
[TBL] [Abstract][Full Text] [Related]
26. [Peripheral hemodynamic and biological effects of perindopril in the healthy subject. Dose-effect relationship].
Richer C; Thuillez C; Desmichels D; Giudicelli JF
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):913-8. PubMed ID: 3026273
[TBL] [Abstract][Full Text] [Related]
27. Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.
Cawello W; Boekens H; Waitzinger J; Miller U
Int J Clin Pharmacol Ther; 2002 Jan; 40(1):9-17. PubMed ID: 11837383
[TBL] [Abstract][Full Text] [Related]
28. A double-blind, placebo-controlled study to assess tolerability, pharmacokinetics and preliminary pharmacodynamics of single escalating doses of Z13752A, a novel dual inhibitor of the metalloproteases ACE and NEP, in healthy volunteers.
Bani M; Colantoni A; Guillaume M; Macchi F; Moroni G; Persiani S
Br J Clin Pharmacol; 2000 Oct; 50(4):338-49. PubMed ID: 11012557
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the bioequivalence and pharmacokinetics of two lisinopril tablet formulations after single oral administration in healthy volunteers.
Georgarakis M; Tsakalof A; Zougrou F; Kontopoulos G; Tsiptsios I
Arzneimittelforschung; 2004; 54(1):15-9. PubMed ID: 14979604
[TBL] [Abstract][Full Text] [Related]
30. Effect of lisinopril and isosorbide-5-mononitrate on hemodynamics and mortality in rats with permanent coronary artery occlusion.
Riva E; Kurosaki M; Latini R
J Cardiovasc Pharmacol; 1992 Sep; 20(3):490-5. PubMed ID: 1279297
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
Azizi M; Bissery A; Peyrard S; Guyene TT; Ozoux ML; Floch A; Ménard J
Clin Pharmacol Ther; 2006 Jan; 79(1):49-61. PubMed ID: 16413241
[TBL] [Abstract][Full Text] [Related]
32. A clinical pharmacological study of nifedipine and lisinopril alone and in combination.
Lees KR; Meredith PA; Reid JL
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S105-7. PubMed ID: 2455105
[TBL] [Abstract][Full Text] [Related]
33. Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinopril.
Nwachukwu DC; Aneke EI; Obika LF; Nwachukwu NZ
Indian J Pharmacol; 2015; 47(5):540-5. PubMed ID: 26600645
[TBL] [Abstract][Full Text] [Related]
34. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses.
Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemeier T; Rush JE
Am Heart J; 1988 Aug; 116(2 Pt 1):480-8. PubMed ID: 2840815
[TBL] [Abstract][Full Text] [Related]
35. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
Bendtsen F; Henriksen JH
J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636
[TBL] [Abstract][Full Text] [Related]
36. Comparison of angiotensin-converting enzyme inhibitors in the rat in perfused hindlimbs and in vivo.
Nelissen-Vrancken MH; Leenders PJ; Bost JG; Struijker-Boudier HA; Smits JF
Eur J Pharmacol; 1992 Jun; 217(1):49-55. PubMed ID: 1327817
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
August P; Cody RJ; Sealey JE; Laragh JH
Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat after intravenous and oral doses of ramipril in healthy horses.
Serrano-Rodríguez JM; Gómez-Díez M; Esgueva M; Castejón-Riber C; Mena-Bravo A; Priego-Capote F; Serrano Caballero JM; Muñoz A
Vet J; 2016 Feb; 208():38-43. PubMed ID: 26639833
[TBL] [Abstract][Full Text] [Related]
39. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
[TBL] [Abstract][Full Text] [Related]
40. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Campbell DJ; Kladis A; Duncan AM
Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
